Colchicine Has Anti-diabetic Effect
1 other identifier
observational
150
1 country
1
Brief Summary
Colchicine has antidiabetic effect and may be an option for type 2 diabetes management
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2020
CompletedFirst Submitted
Initial submission to the registry
May 2, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 2, 2020
CompletedFirst Posted
Study publicly available on registry
May 6, 2020
CompletedMay 6, 2020
May 1, 2020
7 months
May 2, 2020
May 5, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
colchicine for treatment of type diabetes patients
colchicine tablets .5 mg twice daily for 6 months
6 months
Study Arms (3)
group 1 on cochicine
The first group patients received colchicine 0.5 twice daily for 6 months
group 2 on glucophage 1 gm twice daily
second group received glucophage 1gm twice daily for 6 months
group 3 control
the third group patients were on diet only for 6 months
Interventions
colchicine tabletes for 6 months
Eligibility Criteria
Observational cohort prospective study with following of 150 newly diagnosed type 2 diabetes patients who were in 3 groups, had been monitored in a private clinic, each group 50 patients number, with 30 females and 20 males after written consent from all patients. The ages of all patients were between 35 and 55 years.
You may qualify if:
- type 2 diabetes newly diagnosed age 35- 55 years
You may not qualify if:
- severe anemia hypothyroidism and hyperthyroidism moderate to severe liver or kidney disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mahmoud Younis
Cairo, 11865, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- consultant
Study Record Dates
First Submitted
May 2, 2020
First Posted
May 6, 2020
Study Start
October 10, 2019
Primary Completion
May 1, 2020
Study Completion
May 2, 2020
Last Updated
May 6, 2020
Record last verified: 2020-05